{
    "clinical_study": {
        "@rank": "67216", 
        "arm_group": [
            {
                "arm_group_label": "Group A", 
                "arm_group_type": "Active Comparator", 
                "description": "12 sessions of Cognitive-behavioral group therapy in the first 12 weeks"
            }, 
            {
                "arm_group_label": "Group B", 
                "arm_group_type": "Active Comparator", 
                "description": "12 sessions of Cognitive-behavioral group therapy in the second 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "Depression is common in end-stage renal disease (ESRD) patients and has a negative effect on\n      the quality of life, functional ability, and mortality, with a prevalence rate as high as\n      20-25%. However, it is hard to use anti-depressant due to the safety issue, and there has\n      been little data so far particularly in terms of randomized clinical trials. Here, we\n      investigate the effect of cognitive-behavioral group therapy for enhancing mental health and\n      quality of life in patients with ESRD."
        }, 
        "brief_title": "Cognitive-behavioral (CBT) in ESRD Patients With Depression", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Kidney Failure, Chronic", 
            "Depression", 
            "Quality of Life"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Kidney Failure, Chronic", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with end-stage renal disease : on hemodialysis more than 3 months\n\n          -  Patients with BDI-II score >= 15 points\n\n          -  Adult with age >= 20 years old\n\n          -  Patients who were able to understand and willing to sign the written informed consent\n\n        Exclusion Criteria:\n\n          -  Patients on hemodialysis due to acute kidney injury\n\n          -  Patients who are on admission\n\n          -  Patients who are undergoing chemotherapy or radiation therapy due to progressive\n             malignant disease\n\n          -  Patients who are planning kidney transplantation within few months\n\n          -  Patients with cognitive dysfunction, mental retardation, and drug addict\n\n          -  Patients who are unavailable for adequate communication with researchers\n\n          -  Patients who changed anti-depressive agent or dose within 2 months before/after the\n             trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "34", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02011139", 
            "org_study_id": "CBT-ESRD"
        }, 
        "intervention": {
            "arm_group_label": [
                "Group A", 
                "Group B"
            ], 
            "intervention_name": "Cognitive-behavioral group therapy", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Boramae Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effectiveness of Cognitive-behavioral Group Therapy for Enhancing Mental Health and Quality of Life in Maintenance Hemodialysis Patients", 
        "overall_official": {
            "affiliation": "Seoul National University Boramae Hospital", 
            "last_name": "Chun Soo Lim, M.D. PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Beck Depression Inventory-II (BDI-II) score", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02011139"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Boramae Hospital", 
            "investigator_full_name": "Chun Soo Lim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Hamilton Depression Rating Scale (HAMD-17): assessment for depressive mood", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Beck Anxiety Inventory (BAI)", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "The Perceived Stress Scale", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "KD-QOL: quality of life related with kidney disease", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "WHOQOL_BREF: overall quality of life", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Temperament and Character Inventory (TCI)", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Diagnosis of major depressive disorder by DSM-IV", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Biomarker related with depression: serotonin level and etc.", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Additional anti-depressant use after trial", 
                "measure": "Secondary assessment tools for depression,anxiety, and quality of life", 
                "safety_issue": "Yes", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Seoul National University Boramae Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Boramae Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}